secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2021-07-23T23:59:59+00:00
Accession:  0001493152-21-017640
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intec Parent appoints board, officers, and amends charter/bylaws
----------------------------------------------------------------

- Appointed Hila Karah, Anthony Maddaluna, William Hayes, and Dr. Roger Pomerantz as directors; Pomerantz as Chairman.
- Jeffrey Meckler continues as director; officers: Meckler CEO, Nir Sassi CFO, Walt Linscott CBO.
- Board committees formed: Audit (Hayes chair, Pomerantz, Karah), Compensation (Maddaluna chair, Hayes), Nominating (Pomerantz chair, Maddaluna).
- Amended and restated certificate of incorporation and bylaws adopted effective July 23, 2021.
- Intec Israel authorized share capital: 17.5M ordinary shares, 7,370,883 outstanding (as of July 23, 2021).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-017640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer